Home > Healthcare > Healthcare IT > Telehealth > Telepharmacy Market

Telepharmacy Market – By Software & Services, By End Use – Growth Forecast, 2024 - 2032

  • Report ID: GMI12100
  • Published Date: Nov 2024
  • Report Format: PDF

Telepharmacy Market Size

The global telepharmacy market size was valued at USD 9.9 billion in 2023 and is estimated to grow at a CAGR of 10.4% from 2024 to 2032. Telepharmacy refers to the use of telecommunications technology to provide pharmaceutical care remotely. This practice enables pharmacists to deliver services such as medication counseling, prescription verification, and patient monitoring without requiring in-person visits. Telepharmacy enhances access to pharmaceutical services, especially in underserved areas, and allows for more efficient medication management.
 

telepharmacy market

The market is witnessing significant growth fueled by the increasing need for accessible healthcare solutions, particularly in rural and underserved areas where pharmacy services are limited. Telepharmacy enables patients to receive prescriptions, counseling, and medication management from licensed pharmacists through digital platforms, improving convenience and reducing travel burdens. The COVID-19 pandemic accelerated telepharmacy adoption as healthcare providers sought safe, remote care solutions.
 

For instance, according to a January 2022 article titled "Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatient Populations During the COVID-19 Pandemic," published in Europe PMC, patients with telepharmacy access experienced a reduced rise in hospitalization rates compared to those without access, highlighting the impact of telepharmacy on outpatient care during COVID-19. The pandemic positively influenced the telepharmacy market, as healthcare providers sought alternatives for safe, remote patient interaction. Additionally, the market is projected to grow further, supported by the global rise in smartphone usage, which facilitates easy access to telepharmacy services for a broader patient base.
 

Furthermore, technological advancements, such as secure video conferencing and digital health records, further support telepharmacy growth by enhancing patient engagement and healthcare efficiency.
 

Telepharmacy Market Trends

Enhanced internet connectivity and the proliferation of smartphones facilitate remote consultations, prescription management, and patient monitoring. Furthermore, innovative software solutions improve communication between pharmacists and patients, ensuring secure and efficient interactions. These technological improvements streamline pharmacy operations, increase accessibility, and foster patient engagement. As digital health continues to evolve, the integration of advanced telecommunication and software systems will further propel the market.
 

Consequently, despite the strong potential in telepharmacy, challenges such as data security, privacy concerns, regulatory frameworks, and licensing requirements hinder broader adoption. Addressing these issues is crucial to ensure safe, ethical practices and prevent limitations to market growth.
 

Telepharmacy Market Analysis

Telepharmacy Market, By Software & Services, 2021 - 2032 (USD Billion)

Based on software & services, the global market is segmented into software and services. The software segment dominated the market and is anticipated to grow at 10.7% CAGR over the forecast period. The software segment was further categorized into on-premises and web-based/cloud-based.
 

  • The software segment's leadership was fueled by the growing need for robust platforms that support remote consultations, prescription management, and patient monitoring.
     
  • Advanced telepharmacy software enables secure video conferencing, real-time data sharing, and streamlined communication between pharmacists and patients.
     
  • The segment’s growth is also driven by rising investments in healthcare IT and the need for compliance with data privacy regulations.
     
  • As digital health adoption grows, the software segment remains pivotal in enhancing accessibility, medication adherence, and overall patient engagement in telepharmacy.
     
Telepharmacy Market, By End Use (2023)

Based on the end use in the global telepharmacy market is categorized into hospitals pharmacies, retail pharmacies, and other end users. The hospitals pharmacies segment accounted for the highest market share of 49.2% in 2023.
 

  • The dominance of hospital pharmacies was fueled by the increasing adoption of telepharmacy services to manage remote consultations, medication management, and patient counseling efficiently.
     
  • Hospital pharmacies benefit from telepharmacy by extending pharmaceutical care to rural and underserved areas, reducing patient travel, and maintaining continuity of care post-discharge.
     
  • Additionally, the demand for telepharmacy surged during the COVID-19 pandemic, as hospitals sought to minimize in-person contact while ensuring medication adherence and access.
     
  • This trend underscored the pivotal role of hospital pharmacies in leading market adoption and expansion.
     
U.S. Telepharmacy Market, 2021- 2032 (USD Billion)

In 2023, the U.S. held a leading position in the North American market and is projected to maintain this dominance throughout the forecast period, with a CAGR of 10.1%.
 

  • The U.S. holds a prominent position in the North American telepharmacy market, driven by advanced healthcare infrastructure, widespread internet access, and a high adoption rate of digital health solutions.
  • The COVID-19 pandemic further accelerated telepharmacy demand as healthcare providers embraced remote medication management to reduce in-person visits.

     
  • Additionally, supportive regulations and a focus on improving rural healthcare access have spurred market growth across the U.S.
     
  • With increasing investments in healthcare IT and telecommunication advancements, the U.S. continues to lead in telepharmacy innovation and implementation within North America.
     

China holds the highest share in the Asia Pacific telepharmacy market in 2023.
 

  • China stands out in the Asia Pacific market due to its large population, rapid technological advancements, and increasing demand for accessible healthcare solutions.
     
  • The market growth in China has been bolstered by government support, policies promoting digital health, and a strong infrastructure for telecommunication technologies.
     
  • Additionally, China's focus on improving healthcare access in rural areas, coupled with a high rate of smartphone adoption, facilitates telepharmacy expansion. With continued investment in healthcare IT and digital health initiatives, China is expected to maintain its leadership in Asia Pacific market.
     

Germany held a prominent position in the Europe telepharmacy market.
 

  • Germany holds a prominent position in the European market, supported by its advanced healthcare system, strong regulatory frameworks, and high digital health adoption.
     
  • The German government’s initiatives to expand telemedicine and digital healthcare services, particularly in rural areas, have driven market growth.
     
  • Additionally, Germany’s robust infrastructure for secure data management and its emphasis on patient privacy align well with telepharmacy requirements, further boosting market adoption.
     

Brazil accounted for the highest revenue in the Latin American telepharmacy market
 

  • Brazil's prominence was driven by its large population, expanding healthcare infrastructure, and rising demand for remote healthcare services.
     
  • The Brazilian government’s initiatives to improve healthcare access in underserved areas have accelerated telepharmacy adoption, allowing for greater reach and efficiency in pharmaceutical care.
     
  • Additionally, increasing smartphone penetration and telecommunication advancements support the widespread use of telepharmacy platforms. With these factors, Brazil leads the Latin American market and is expected to continue its strong growth.
     

Saudi Arabia is poised to grow at a significant growth rate in the Middle East and African telepharmacy market.
 

  • Saudi Arabia is poised for significant growth in the Middle East and African market, driven by the government’s commitment to enhancing healthcare access and integrating digital health solutions.
     
  • The Vision 2030 initiative aims to modernize the healthcare sector, promoting digital technologies, including telemedicine and telepharmacy services, to improve patient care, particularly in rural areas.
     
  • Additionally, increasing smartphone adoption and internet connectivity facilitate the use of telepharmacy platforms. With ongoing investments in healthcare infrastructure and technology, Saudi Arabia is well-positioned to lead the region in telepharmacy growth.
     

Telepharmacy Market Share

The market features a mix of established healthcare IT companies and emerging startups. Key players leverage their extensive pharmacy networks and technological capabilities to enhance telepharmacy services. Emerging companies focus on innovative solutions that improve medication management and patient engagement. In addition, the market is characterized by rapid technological advancements, leading to collaborations and partnerships aimed at expanding service offerings. Additionally, regulatory compliance and data security remain critical competitive factors as companies strive to build trust and ensure safe telepharmacy practices.
 

Telepharmacy Market Companies

Few of the prominent players operating in the telepharmacy industry include:

  • AZOVA
  • Cardinal Health
  • CarepathRx
  • CPS Solutions
  • Indispensable Health
  • Infinipharm
  • Medication Review
  • OSP
  • Outcomes
  • PipelineRx
  • Right ePharmacy
  • Zane Networks
     

Telepharmacy Industry News

  • In August 2021, Bayer, in collaboration with Alpro Pharmacy, BIG Pharmacy, and DOC2US, launched the first telepharmacy focused on empowering women regarding their reproductive health and family planning. This platform offers accessible oral contraceptives and free consultations with pharmacists, enabling informed decision-making. This initiative aimed to enhance women's health and autonomy in managing reproductive choices.
     
  • In September 2019, PAR, Inc. announced its investment in the local startup RxLive, Inc., a telehealth company dedicated to offering patients access to clinical pharmacists for personalized medication advice. This partnership aims to enhance telepharmacy services and improve medication management for patients, leveraging RxLive's innovative platform to connect individuals with pharmacists for tailored healthcare solutions.
     

The telepharmacy market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report


Market, By Software & Services

  • Software
    • On-premises
    • Web-based/ cloud-based
  • Services
    • Remote dispensing
    • Remote patient counseling
    • Remote order-entry review
    • Drug therapy monitoring
    • Other services

Market, By End Use

  • Hospitals pharmacies
  • Retail pharmacies
  • Other end users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea 
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • Saudi Arabia
    • South Africa
    • UAE

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global telepharmacy industry was valued at USD 9.9 billion in 2023 and is estimated to grow at a 10.4% CAGR from 2024 to 2032, driven by the increasing need for remote pharmaceutical care.

The software segment dominated the market in 2023 and is anticipated to grow at a 10.7% CAGR over the forecast period due to the rising demand for robust platforms supporting remote consultations, prescription management, and patient monitoring.

In 2023, the U.S. held a leading position in the North American market and is projected to maintain this dominance throughout the forecast period, with a CAGR of 10.1%, driven by advanced healthcare infrastructure and high adoption of digital health solutions.

Key players in the telepharmacy sector include AZOVA, Cardinal Health, CarepathRx, CPS Solutions, Indispensable Health, Infinipharm, Medication Review, OSP, Outcomes, PipelineRx, and Right ePharmacy.

Telepharmacy Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 120
  • Countries covered: 19
  • Pages: 140
 Download Free Sample